Literature DB >> 33384894

Evidence-Based Approaches to Glaucoma Management During Pregnancy and Lactation.

Susie C Drake1, Thasarat S Vajaranant1.   

Abstract

With increasing maternal age in this decade, there is a parallel rise in the number of pregnant and lactating women affected by glaucoma worldwide. Understanding the diagnosis and management of glaucoma during pregnancy and lactation is essential to preventing blindness from glaucoma in this vulnerable population. This report provides a review of the current literature and offers effective strategies that will overcome the challenges in managing glaucoma during pregnancy and lactation. Practically, glaucoma management during pregnancy and lactation presents a unique challenge for the physician, as the benefit of any treatment must be weighed against the potential risks to the fetus. Prior to initiating or continuing treatment, the physician should be familiar with the various treatment options to manage intraocular pressure during pregnancy and lactation, including the safety of various anti-glaucoma medications as supported by the existing literature and based on the food and drug administration guidelines. A collaborative team effort between the ophthalmologist, obstetrician, and neonatologist in high-risk pregnancies is recommended to optimize care for the mother and fetus.

Entities:  

Keywords:  Estrogen; Female sex hormone; Glaucoma; Intraocular pressure; Lactation; Pregnancy

Year:  2016        PMID: 33384894      PMCID: PMC7773175          DOI: 10.1007/s40135-016-0112-1

Source DB:  PubMed          Journal:  Curr Ophthalmol Rep        ISSN: 2167-4868


  46 in total

1.  The ocular hypotensive effect of late pregnancy is higher in multigravidae than in primigravidae.

Authors:  I A Qureshi; X R Xi; T Yaqob
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2000-01       Impact factor: 3.117

2.  Effect of third trimester of pregnancy on diurnal variation of ocular pressure.

Authors:  I A Qureshi; X R Xi; X D Wu; N Pasha; Y B Huang
Journal:  Chin Med Sci J       Date:  1997-12

3.  Female reproductive factors and open angle glaucoma: the Blue Mountains Eye Study.

Authors:  A J Lee; P Mitchell; E Rochtchina; P R Healey
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

4.  Topical timolol therapy in pregnancy: is it safe for the fetus?

Authors:  A M Wagenvoort; J M van Vugt; M Sobotka; H P van Geijn
Journal:  Teratology       Date:  1998-12

5.  Intraocular pressure and pregnancy: a comparison between normal and ocular hypertensive subjects.

Authors:  I A Qureshi
Journal:  Arch Med Res       Date:  1997       Impact factor: 2.235

6.  [Use of glaucoma medications during pregnancy and breastfeeding].

Authors:  C Méndez-Hernández
Journal:  Arch Soc Esp Oftalmol       Date:  2012-12

Review 7.  American Academy of Pediatrics Committee on Drugs: Transfer of drugs and other chemicals into human milk.

Authors: 
Journal:  Pediatrics       Date:  1989-11       Impact factor: 7.124

8.  The use of acetazolamide in idiopathic intracranial hypertension during pregnancy.

Authors:  Andrew G Lee; Misha Pless; Julie Falardeau; Tammy Capozzoli; Michael Wall; Randy H Kardon
Journal:  Am J Ophthalmol       Date:  2005-05       Impact factor: 5.258

9.  Effects of Hormone Therapy on Intraocular Pressure: The Women's Health Initiative-Sight Exam Study.

Authors:  Thasarat S Vajaranant; Pauline M Maki; Louis R Pasquale; Anne Lee; Hajwa Kim; Mary N Haan
Journal:  Am J Ophthalmol       Date:  2016-03-03       Impact factor: 5.258

10.  Topical intraocular pressure therapy effects on pregnancy.

Authors:  Carmen Mendez-Hernandez; Julian Garcia-Feijoo; Federico Saenz-Frances; Enrique Santos-Bueso; Jose Maria Martinez-de-la-Casa; Alicia Valverde Megias; Ana M Fernández-Vidal; Julian Garcia-Sanchez
Journal:  Clin Ophthalmol       Date:  2012-10-08
View more
  1 in total

1.  Glaucoma Progression after Delivery in Patients with Open-Angle Glaucoma Who Discontinued Glaucoma Medication during Pregnancy.

Authors:  Duri Seo; Taekjune Lee; Joo Yeon Kim; Gong Je Seong; Wungrak Choi; Hyong Won Bae; Chan Yun Kim
Journal:  J Clin Med       Date:  2021-05-19       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.